BLI (BLI) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 95 252 sessions, March 21, 2022 to March 21, 2023
- Largest daily move
- +24.7% close of December 22, 2022
- 1-year change
- -83% closing prices, March 21, 2022 to March 21, 2023
Company Description
BLI (Nasdaq: BLI) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $86.6M.
BLI has declined 83.0% over the past year. The last closing price was $1.20.
This page collects what Stock Titan holds for BLI, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BLI (BLI) closed at $1.20 on March 21, 2023. Over the past 12 months, the price has lost 83.0%.
BLI Metrics & Rankings
Price returns through March 21, 2023. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
BLI has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 4 with negative movement. Key topics include acquisition, conferences, earnings, management. View all BLI news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BLI Company Profile & Sector Positioning
BLI (BLI) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing BLI often look at related companies in the same sector, including Nautilus Biotechnology Inc (NAUT), Champions Oncolo (CSBR), Atara Biotherape (ATRA), Nutriband Inc (NTRB), and Immunoprecise (IPA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BLI's relative position within its industry.